232 related articles for article (PubMed ID: 36769163)
1. Plant Coumarins with Anti-HIV Activity: Isolation and Mechanisms of Action.
Sharapov AD; Fatykhov RF; Khalymbadzha IA; Zyryanov GV; Chupakhin ON; Tsurkan MV
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769163
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 reverse transcriptase activity by cordatolides isolated from Calophyllum cordato-oblongum.
Dharmaratne HR; Wanigasekera WM; Mata-Greenwood E; Pezzuto JM
Planta Med; 1998 Jun; 64(5):460-1. PubMed ID: 9690350
[TBL] [Abstract][Full Text] [Related]
3. Coumarins as inhibitors of HIV reverse transcriptase.
Kostova I
Curr HIV Res; 2006 Jul; 4(3):347-63. PubMed ID: 16842086
[TBL] [Abstract][Full Text] [Related]
4. [Progress in HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
Zhou T; Xie L
Yao Xue Xue Bao; 2004 Aug; 39(8):666-72. PubMed ID: 15563074
[No Abstract] [Full Text] [Related]
5. In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI.
Xu ZQ; Buckheit RW; Stup TL; Flavin MT; Khilevich A; Rizzo JD; Lin L; Zembower DE
Bioorg Med Chem Lett; 1998 Aug; 8(16):2179-84. PubMed ID: 9873509
[TBL] [Abstract][Full Text] [Related]
6. Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide.
Buckheit RW; White EL; Fliakas-Boltz V; Russell J; Stup TL; Kinjerski TL; Osterling MC; Weigand A; Bader JP
Antimicrob Agents Chemother; 1999 Aug; 43(8):1827-34. PubMed ID: 10428899
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication.
Buckheit RW; Russell JD; Xu ZQ; Flavin M
Antivir Chem Chemother; 2000 Sep; 11(5):321-7. PubMed ID: 11142630
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors.
Hizi A; Tal R; Shaharabany M; Currens MJ; Boyd MR; Hughes SH; McMahon JB
Antimicrob Agents Chemother; 1993 May; 37(5):1037-42. PubMed ID: 7685994
[TBL] [Abstract][Full Text] [Related]
9. Distribution of pyranocoumarins in Calophyllum cordato-oblongum.
Dharmaratne HR; Mayuri Sajeevani JR; Marasinghe GP; Shantha Ekanayake EM
Phytochemistry; 1998 Oct; 49(4):995-8. PubMed ID: 9788146
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.
Dharmaratne HR; Tan GT; Marasinghe GP; Pezzuto JM
Planta Med; 2002 Jan; 68(1):86-7. PubMed ID: 11842340
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.
Currens MJ; Gulakowski RJ; Mariner JM; Moran RA; Buckheit RW; Gustafson KR; McMahon JB; Boyd MR
J Pharmacol Exp Ther; 1996 Nov; 279(2):645-51. PubMed ID: 8930167
[TBL] [Abstract][Full Text] [Related]
12. Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C).
Zembower DE; Liao S; Flavin MT; Xu ZQ; Stup TL; Buckheit RW; Khilevich A; Mar AA; Sheinkman AK
J Med Chem; 1997 Mar; 40(6):1005-17. PubMed ID: 9083491
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase.
Quan Y; Motakis D; Buckheit R; Xu ZQ; Flavin MT; Parniak MA; Wainberg MA
Antivir Ther; 1999; 4(4):203-9. PubMed ID: 10723499
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A.
Currens MJ; Mariner JM; McMahon JB; Boyd MR
J Pharmacol Exp Ther; 1996 Nov; 279(2):652-61. PubMed ID: 8930168
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors.
Tarby CM
Curr Top Med Chem; 2004; 4(10):1045-57. PubMed ID: 15193138
[TBL] [Abstract][Full Text] [Related]
16. F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis.
Lu X; Liu L; Zhang X; Lau TC; Tsui SK; Kang Y; Zheng P; Zheng B; Liu G; Chen Z
Antimicrob Agents Chemother; 2012 Jan; 56(1):341-51. PubMed ID: 22037848
[TBL] [Abstract][Full Text] [Related]
17. Coumarins as Potential Inhibitors of DNA Polymerases and Reverse Transcriptases. Searching New Antiretroviral and Antitumoral Drugs.
Garro HA; Pungitore CR
Curr Drug Discov Technol; 2015; 12(2):66-79. PubMed ID: 26179474
[TBL] [Abstract][Full Text] [Related]
18. Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.
Boyer PL; Currens MJ; McMahon JB; Boyd MR; Hughes SH
J Virol; 1993 Apr; 67(4):2412-20. PubMed ID: 7680393
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
[TBL] [Abstract][Full Text] [Related]
20. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR
J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
